Advertisement
New Zealand markets close in 51 minutes
  • NZX 50

    11,714.80
    -150.09 (-1.27%)
     
  • NZD/USD

    0.6129
    -0.0015 (-0.25%)
     
  • NZD/EUR

    0.5724
    -0.0009 (-0.16%)
     
  • ALL ORDS

    7,962.80
    -12.00 (-0.15%)
     
  • ASX 200

    7,719.70
    -4.60 (-0.06%)
     
  • OIL

    78.18
    -0.27 (-0.34%)
     
  • GOLD

    2,339.40
    -9.70 (-0.41%)
     
  • NASDAQ

    19,659.80
    +82.90 (+0.42%)
     
  • FTSE

    8,146.86
    -16.81 (-0.21%)
     
  • Dow Jones

    38,589.16
    -57.94 (-0.15%)
     
  • DAX

    18,002.02
    -263.68 (-1.44%)
     
  • Hang Seng

    17,982.93
    +41.15 (+0.23%)
     
  • NIKKEI 225

    38,040.47
    -774.09 (-1.99%)
     
  • NZD/JPY

    96.4130
    -0.2390 (-0.25%)
     

Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference

Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation

PRINCETON, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the 2024 Bank of America Healthcare conference on Tuesday, May 14, 2024 at 4:40pm ET.

A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at http://investor.integralife.com/events-and-presentations.

About Integra LifeSciences
At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic, and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands that include Acclarent®, AmnioExcel®, Aurora®, Bactiseal®, BioD™, CerebroFlo®, CereLink® Certas® Plus, Codman®, CUSA®, Cytal®, DuraGen®, DuraSeal®, DuraSorb®, Gentrix®, ICP Express®, Integra®, Licox®, MAYFIELD®, MediHoney®, MicroFrance®, MicroMatrix®, NeuraGen®, NeuraWrap™, PriMatrix®, SurgiMend®, TCC-EZ® and VersaTru®. For the latest news and information about Integra and its products, please visit www.integralife.com.

Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com 

Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com

Integra LifeSciences Holdings Corporation